Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-001185-91Phase 2Completed
Phase 2, randomised, double-blind trial of betamethasone in ataxia-telangiectasia (AT) (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Neurological symptoms change. Started May 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-001185-91.